FOXO1 and chronic obstructive pulmonary disease: In COPD, the expression of markers of the proteolysis pathway, such as the ubiquitin ligases atrogin-1 and MuRF1 and the transcription factors FoxO1 and FoxO3, are increased in the atrophic muscle of patients compared with controls [2–4].